Boehnlein Glenn S bought DXCM

September 10, 2026 · Form 4 insider transaction

Boehnlein Glenn S bought 5,841 shares of DexCom, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
5,841
Price
$0.00
Total value
N/A
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateSeptember 10, 2026
Filing dateSeptember 10, 2026
Shares owned after5,841
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

View the original Form 4 on SEC EDGAR